InvestorsHub Logo
Followers 9
Posts 740
Boards Moderated 0
Alias Born 01/15/2014

Re: None

Friday, 03/11/2016 1:34:09 PM

Friday, March 11, 2016 1:34:09 PM

Post# of 27409
CEO: Wrack your brain

Just a heads-up on strokes/brain swelling application that could just burst into the market!

Could an adjunctive cytosorb filter help ameliorate the "hyper inflammatory cascade"
in ischemic stroke (or any other traumatic brain injury, TBI, for that matter)?

If so, how large could that addressable market be?

Mind you, there are probably shades of grey here, but this just might be a no brainer.


"It's all in the data. Athersys continues to demonstrate that MultiStem has a meaningful clinical benefit in patients who have suffered an ischemic stroke and may extend the therapeutic window to 36 hours, as well as ameliorate some of the natural AEs (hyper inflammatory cascade), which tend to leave patients in an immune-depressed state (such as secondary infections and or pulmonary complications associated with stroke)."

Mind boggling, huh?

http://seekingalpha.com/news/3166757-athersys-maxim-doubles-price-target-10-sees-446-percent-upside?uprof=54#email_link

Why not give it some thought? the mind-numbing potential of it!!
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CTSO News